Denali Therapeutics IncNASDAQ:DNLI
- LAST PRICE30.9100
- TODAY'S CHANGE (%)-0.1400 (-0.4509%)
- Bid / Lots27.9400/ 1
- Ask / Lots30.9000/ 1
- Open / Previous Close30.9400 / 31.0500
- Day Range
- 52 Week Range
- Volume1,997,843
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNLI |
|---|---|---|
| 09:32 ET | 221495 | 31.05 |
| 09:34 ET | 2000 | 31 |
| 09:36 ET | 3931 | 31.17 |
| 09:39 ET | 300 | 31.04 |
| 09:41 ET | 300 | 30.81 |
| 09:43 ET | 300 | 30.895 |
| 09:45 ET | 200 | 30.8 |
| 09:48 ET | 400 | 30.875 |
| 09:50 ET | 300 | 30.82 |
| 09:52 ET | 349 | 30.81 |
| 09:54 ET | 200 | 30.79 |
| 09:56 ET | 100 | 30.78 |
| 09:57 ET | 200 | 30.75 |
| 09:59 ET | 100 | 30.795 |
| 10:01 ET | 1798 | 30.885 |
| 10:03 ET | 11532 | 31.065 |
| 10:06 ET | 1600 | 31.09 |
| 10:08 ET | 400 | 31.09 |
| 10:10 ET | 1453 | 31.18 |
| 10:12 ET | 400 | 31.09 |
| 10:14 ET | 1346 | 31.095 |
| 10:15 ET | 900 | 31.085 |
| 10:17 ET | 1100 | 31.09 |
| 10:19 ET | 800 | 31.1 |
| 10:21 ET | 3800 | 31.06 |
| 10:24 ET | 200 | 31.06 |
| 10:26 ET | 8016 | 31.05 |
| 10:28 ET | 1118 | 31.08 |
| 10:30 ET | 543 | 31.015 |
| 10:32 ET | 300 | 30.995 |
| 10:33 ET | 700 | 30.89 |
| 10:35 ET | 574 | 30.93 |
| 10:37 ET | 700 | 31.0025 |
| 10:39 ET | 500 | 30.97 |
| 10:42 ET | 818 | 31.03 |
| 10:44 ET | 952 | 31.095 |
| 10:46 ET | 500 | 31.17 |
| 10:48 ET | 300 | 31.125 |
| 10:50 ET | 1239 | 31.13 |
| 10:51 ET | 1650 | 31.06 |
| 10:55 ET | 100 | 31.045 |
| 10:57 ET | 1053 | 31.06 |
| 11:00 ET | 700 | 31.06 |
| 11:02 ET | 1092 | 31.055 |
| 11:04 ET | 800 | 30.935 |
| 11:06 ET | 600 | 30.92 |
| 11:08 ET | 1000 | 30.87 |
| 11:09 ET | 300 | 30.84 |
| 11:11 ET | 400 | 30.82 |
| 11:13 ET | 1445 | 30.85 |
| 11:15 ET | 100 | 30.84 |
| 11:18 ET | 200 | 30.8 |
| 11:22 ET | 4346 | 30.785 |
| 11:24 ET | 100 | 30.79 |
| 11:26 ET | 100 | 30.75 |
| 11:27 ET | 500 | 30.84 |
| 11:29 ET | 200 | 30.85 |
| 11:31 ET | 800 | 30.73 |
| 11:33 ET | 1600 | 30.76 |
| 11:36 ET | 1314 | 30.81 |
| 11:38 ET | 221 | 30.87 |
| 11:40 ET | 500 | 30.96 |
| 11:44 ET | 2271 | 30.92 |
| 11:45 ET | 100 | 30.94 |
| 11:47 ET | 233 | 30.91 |
| 11:51 ET | 600 | 30.91 |
| 11:54 ET | 700 | 30.86 |
| 11:56 ET | 600 | 30.89 |
| 11:58 ET | 2401 | 30.905 |
| 12:00 ET | 200 | 30.88 |
| 12:02 ET | 100 | 30.855 |
| 12:03 ET | 505 | 30.85 |
| 12:05 ET | 400 | 30.855 |
| 12:07 ET | 1350 | 30.839 |
| 12:09 ET | 900 | 30.915 |
| 12:12 ET | 900 | 30.93 |
| 12:14 ET | 413 | 30.9 |
| 12:16 ET | 400 | 30.875 |
| 12:18 ET | 100 | 30.87 |
| 12:20 ET | 202 | 30.87 |
| 12:21 ET | 1100 | 30.885 |
| 12:23 ET | 998 | 30.89 |
| 12:25 ET | 827 | 30.9 |
| 12:27 ET | 400 | 30.89 |
| 12:30 ET | 2081 | 30.865 |
| 12:32 ET | 57389 | 30.78 |
| 12:34 ET | 319 | 30.835 |
| 12:36 ET | 420 | 30.82 |
| 12:39 ET | 3213 | 30.77 |
| 12:43 ET | 450 | 30.73 |
| 12:45 ET | 1068 | 30.75 |
| 12:48 ET | 200 | 30.7 |
| 12:50 ET | 800 | 30.77 |
| 12:52 ET | 200 | 30.795 |
| 12:54 ET | 500 | 30.821 |
| 12:57 ET | 400 | 30.82 |
| 12:59 ET | 100 | 30.86 |
| 01:01 ET | 500 | 30.84 |
| 01:03 ET | 700 | 30.8 |
| 01:10 ET | 300 | 30.89 |
| 01:12 ET | 300 | 30.92 |
| 01:14 ET | 400 | 30.87 |
| 01:15 ET | 400 | 30.92 |
| 01:17 ET | 3300 | 30.91 |
| 01:19 ET | 1500 | 30.96 |
| 01:21 ET | 300 | 30.965 |
| 01:24 ET | 5600 | 30.9 |
| 01:26 ET | 3675 | 30.88 |
| 01:28 ET | 227 | 30.88 |
| 01:30 ET | 2580 | 30.9 |
| 01:32 ET | 200 | 30.91 |
| 01:33 ET | 400 | 30.9 |
| 01:35 ET | 500 | 30.87 |
| 01:37 ET | 900 | 30.93 |
| 01:39 ET | 500 | 30.94 |
| 01:42 ET | 900 | 30.9 |
| 01:44 ET | 700 | 30.92 |
| 01:46 ET | 600 | 30.92 |
| 01:48 ET | 4434 | 30.89 |
| 01:50 ET | 600 | 30.87 |
| 01:51 ET | 1900 | 30.88 |
| 01:53 ET | 2700 | 30.84 |
| 01:55 ET | 500 | 30.83 |
| 01:57 ET | 1100 | 30.77 |
| 02:00 ET | 900 | 30.74 |
| 02:02 ET | 2100 | 30.77 |
| 02:04 ET | 300 | 30.76 |
| 02:06 ET | 600 | 30.71 |
| 02:08 ET | 2300 | 30.73 |
| 02:09 ET | 400 | 30.74 |
| 02:11 ET | 400 | 30.72 |
| 02:13 ET | 2100 | 30.8 |
| 02:15 ET | 300 | 30.79 |
| 02:18 ET | 12200 | 30.875 |
| 02:20 ET | 2090 | 30.885 |
| 02:22 ET | 800 | 30.9 |
| 02:24 ET | 100 | 30.895 |
| 02:26 ET | 1025 | 30.89 |
| 02:27 ET | 300 | 30.895 |
| 02:29 ET | 1454 | 30.835 |
| 02:31 ET | 2844 | 30.8 |
| 02:33 ET | 3853 | 30.85 |
| 02:36 ET | 400 | 30.825 |
| 02:38 ET | 927 | 30.83 |
| 02:40 ET | 3184 | 30.855 |
| 02:42 ET | 800 | 30.89 |
| 02:44 ET | 2820 | 30.91 |
| 02:45 ET | 720 | 30.935 |
| 02:47 ET | 600 | 30.94 |
| 02:49 ET | 5207 | 30.985 |
| 02:51 ET | 900 | 30.955 |
| 02:54 ET | 2544 | 30.95 |
| 02:56 ET | 2700 | 30.98 |
| 02:58 ET | 500 | 30.975 |
| 03:00 ET | 1200 | 30.94 |
| 03:02 ET | 1900 | 30.965 |
| 03:03 ET | 1300 | 30.94 |
| 03:05 ET | 887 | 30.92 |
| 03:07 ET | 1971 | 30.995 |
| 03:09 ET | 2474 | 30.99 |
| 03:12 ET | 1200 | 31 |
| 03:14 ET | 400 | 31 |
| 03:16 ET | 814 | 31 |
| 03:18 ET | 1203 | 30.98 |
| 03:20 ET | 2660 | 30.87 |
| 03:21 ET | 2600 | 30.87 |
| 03:23 ET | 3000 | 30.91 |
| 03:25 ET | 868 | 30.89 |
| 03:27 ET | 1481 | 30.941 |
| 03:30 ET | 400 | 31.05 |
| 03:32 ET | 2074 | 31.03 |
| 03:34 ET | 4728 | 31.14 |
| 03:36 ET | 827 | 31.116 |
| 03:38 ET | 1700 | 31.08 |
| 03:39 ET | 2059 | 31.2 |
| 03:41 ET | 2110 | 31.16 |
| 03:43 ET | 2200 | 31.19 |
| 03:45 ET | 2840 | 31.17 |
| 03:48 ET | 1300 | 31.1 |
| 03:50 ET | 2218 | 31.11 |
| 03:52 ET | 5272 | 30.98 |
| 03:54 ET | 2775 | 30.89 |
| 03:56 ET | 11558 | 30.86 |
| 03:57 ET | 10150 | 30.95 |
| 03:59 ET | 1034757 | 30.91 |
Sep 9, 2024
DJ Denali Therapeutics Price Target Maintained With a $35.00/Share by Cantor Fitzgerald, from 11:46AM ET on Monday Sep 09, 2024 by Dow Jones
11:46AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 4, 2024
DJ Denali Therapeutics Is Maintained at Buy by B of A Securities, from 7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
7:47AM ET on Wednesday Sep 04, 2024 by Dow JonesDJ Denali Therapeutics Price Target Maintained With a $90.00/Share by HC Wainwright & Co., from 7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Denali Therapeutics Inc | 4.4B | -10.8x | --- |
Apellis Pharmaceuticals Inc | 4.5B | -11.9x | --- |
Axsome Therapeutics Inc | 4.5B | -14.7x | --- |
CRISPR Therapeutics AG | 4.2B | -15.0x | --- |
ADMA Biologics Inc | 4.6B | 142.1x | --- |
TG Therapeutics Inc | 3.9B | 41.1x | --- |
Company Information
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Contact Information
- Headquarters
- 161 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1910
- Phone
- 650-866-8548
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Vicki Sato
- President, Chief Executive Officer, Director
- Ryan Watts
- Chief Financial Officer, Chief Operating Officer, Company Secretary
- Alexander Schuth
- Chief Medical Officer
- Carole Ho
- Director
- Steven Krognes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.4B |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 143.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-2.85 |
Book Value | $7.45 |
P/E Ratio | -10.8x |
Price/Sales (TTM) | 3,508.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,938.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
